Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

National Cancer Center
National Cancer Center Research Institute
National Cancer Center_20100121

National Cancer Center patents

Recent patent applications related to National Cancer Center. National Cancer Center is listed as an Agent/Assignee. Note: National Cancer Center may have other listings under different names/spellings. We're not affiliated with National Cancer Center, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | National Cancer Center-related inventors

Date National Cancer Center patents (updated weekly) - BOOKMARK this page
07/27/17Method of predicting reaction to sorafenib treatment using gene polymorphism
07/06/17Hnf4-alpha antagonist and use thereof
06/15/17Liver cancer detection kit or device, and detection method
05/11/17Apparatus for controlling stiffness of output link in moving mechanism
05/11/17Esophageal cancer detection kit or device, and detection method
05/11/17Colorectal cancer detection kit or device, and detection method
05/11/17Breast cancer detection kit or device, and detection method
05/11/17Stomach cancer detection kit or device, and detection method
05/11/17Lung cancer detection kit or device, and detection method
05/04/17Prostate cancer detection kit or device, and detection method
04/20/17Biliary tract cancer detection kit or device, and detection method
04/13/17Method for detecting rare mutation
03/16/17Suturing device for surgery
03/16/17Pharmaceutical composition for cancer treatment containing gossypol and phenformin as active ingredients
03/09/17Method for predicting responsiveness to cancer treatment using p300-inhibiting compound
03/02/17Method for determining prognosis of renal cell carcinoma
02/23/17Nanostructure for detecting cell-free dna using conductive polymer and the use thereof
02/02/17Anticancer agent and side-effect-alleviating agent
02/02/17Multipurpose medical image indicator and manufacturing the same
01/19/17Peptides derived from ncapg2 and their use
12/08/16Microrna-based methods and assays for osteosarcoma
12/01/16Peptides derived from ncapg2 and their use
11/17/16Anti-tissue factor monoclonal antibody
11/10/16Method for detecting defective zone of retinal nerve fiber layer
11/10/16Device for detecting therapeutic proton beam emitted in pencil beam scanning mode
11/10/16Device for detecting therapeutic proton beam emitted in scattering mode
11/03/16Novel fusion genes as factors responsible for gastric cancer
10/27/16Medical image processing apparatus
10/20/16Closed loop-type hemostatic clipping device having built-in inner pincers
10/06/16Novel chimeric gene atf7ip-pdgfrb of acute lymphoblastic leukemia
09/15/16Novel quinazoline derivative
09/08/16Injection device for endoscopy
09/08/16Monoclonal antibody which specifically recognizes b cell lymphoma and use thereof
08/25/16Novel epitope for switching to th17 cell and use thereof
08/25/16Method for detecting pancreatic tumor, antibodies, and kit for the detection of pancreatic tumor
08/18/16Skull implant type medication injection port
08/04/16Blood cell aggregating agent for preparing paraffin block and preparing paraffin block by using same
08/04/16Gastric cancer cell line derived from murine gastric adenocarcinoma lacking p53 and e-cadherin and use thereof
07/14/16Method for prediction of prognosis by human papillomavirus dna integration pattern
07/07/16Hnf4-alpha antagonist and use thereof
05/12/16Method for predicting response to cancer treatment
03/24/16Analysis method
03/17/16Medical tube
01/28/16Therapeutic agents for pancreatic cancer
01/14/16Pharmaceutical composition for treating cancer
01/14/16Antibody against insoluble fibrin
12/24/15Maker for diagnosing her2 inhibitor resistant cancer, diagnostic kit comprising same, and diagnosing her2 inhibitor resistant cancer
11/26/15Recombinant adenovirus with increased safety and anticancer activities, and use thereof
11/19/15Novel labeling composition for cancer lesion
10/29/15Biotissue sampling apparatus
09/24/15Method to improve the tumor diagnostic efficiency of multivalent ligands by regulating the stoichiometric ratio between inner surface functionalities and ligand moieties for tumor targeting
09/17/15Methods for isolating and proliferating autologous cancer antigen-specific cd8+ t cells
08/27/15Use of adcy3 for diagnosis and treatment of gastric cancer
08/06/15Promoter of differentiation from hepatic progenitor cell into hepatic cell, and use thereof
07/30/15Image generation apparatus and program
07/23/15Apparatus and laser alignment in radiation therapy
07/16/15Anti-cancer agent
07/16/15Peptides derived from ncapg2 and their use
07/16/15Agent for treating cancer
07/16/15Kit for diagnosing malignant melanoma
07/09/15Fgfr2 fusion gene
07/02/15Method for detecting pancreatic cancer and detection kit
06/25/15Fusion gene of cep55 gene and ret gene
05/28/15Composition comprising of a conducting polymer for detecting, capturing, releasing, and collecting cell
05/14/15Novel bicyclic thiazole compounds
Patent Packs
04/30/15Method for predicting prognosis of renal cell carcinoma
02/26/15Novel fusion genes identified in lung cancer
01/22/15Projection-type partially dual-structured stent
09/25/14Recombinant adenovirus comprising trans-splicing ribozyme and cancer-treating gene, and use thereof
08/28/14Mutant ctla4 gene transfected t cell and composition including same for anticancer immunotherapy
08/28/14Microrna-based methods and assays for osteosarcoma
08/07/14Fusion gene of kif5b gene and ret gene, and determining effectiveness of cancer treatment targeting fusion gene
05/15/14Induced malignant stem cells
03/13/14Novel epitope for switching to th17 cell and use thereof
03/13/14Novel epitope for switching to th2 cell and use thereof
03/06/14Novel epitope for switching to th1 cell and use thereof
02/06/14Burdock fruit extract containing arctigenin and producing same
01/16/14Method for assessing risk of hepatocellular carcinoma
01/02/14Composition for aggregating biological sample
12/26/13Pin assembly for operation capable of introducing drug
Patent Packs
11/21/13Sentinel lymph node marker capable of multi-mode imaging
09/05/13Apparatus for cancer diagnosis
08/15/13Method for crystallizing low mass ions for diagnosing colorectal cancer and diagnosing colorectal cancer using same
08/01/13Induced malignant stem cells or pre-induction cancer stem cells capable of selfreplication outside of an organism, production same, and practical application for same
06/13/13Therapeutic agents for pancreatic cancer
04/11/13Charged particle dose simulation device, charged particle beam irradiation device, charged particle dose simulation method, and charged particle beam irradiation method
03/21/13Process for hepatic differentiation from induced hepatic stem cells, and induced hepatic progenitor cells differentiated thereby
02/21/13Composition for cancer prognosis prediction comprising anti-tmap/ckap2 antibodies
01/24/13Induced hepatic stem cell and process for production thereof, and applications of the cell
10/25/12Method for constructing chimeric rat using rat embryonic stem cells
10/04/12Therapeutic agent for tumor
08/09/12Use of eif3m for the diagnosis and treatment of cancer
07/12/12Diagnostic composition for autoimmune diseases comprising agent measuring cd3z gene methylation level and a diagnosing autoimmune diseases using the same
03/22/12Charged particle beam radiation control device and charged particle beam radiation method
02/23/12Positively-charged superparamagnetic iron oxide nanoparticle, contrast agent using the same and preparing the same
01/19/12Photosensitizer-metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis
12/01/11Photosensitizer-metal nanoparticle complex and composition containing the complex for photodynamic therapy or diagnosis
11/24/11Novel cancer targeting therapy using complex of subtance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
10/27/11Therapeutic agent for mll leukemia and moz leukemia of which molecular target is m-csf receptor, and use thereof
10/13/11Method for screening cancer therapeutic agent using galectin-3, gsk-3betta, and fascin-1
06/23/11Apparatus and multiple immunoassays on a chip
06/23/11Apparatus for inserting needle
06/09/11Novel oncogene nrf2
05/26/11Anti-cancer composition comprising microrna molecules
05/05/11Method for measuring chromosome, gene or specific nucleotide sequence copy numbers using snp array
04/21/11Treatment epithelial cancerous organism
03/17/11Hemostatic clip and hemostatic clip operation apparatus using the same
02/17/11Surgical retractor
02/03/11Oligonucleotides-transferring preparations
Social Network Patent Pack
01/27/11Composition containing microrna-21 inhibitor for enhancing radiation sensitivity
12/30/10Surgical transanal endoscopic microsurgery
12/30/10Fluorescent indication clip for surgery
12/16/10Kit for diagnosis of breast cancer using herceptin, a composition comprising herceptin and a detecting herceptin-sensitive her2 overexpressed cell using the same
11/11/10Surgical instrument
10/28/10Surgical instrument
10/07/10Bone graft shaping system and method using the same
09/16/10Pedal input device with three rotational degrees of freedom
01/21/10Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
12/24/09Pin assembly for operation
Patent Packs
10/15/09Method of tracking eyeball in eyeball tumor treatment
03/19/09Method of treating solid tumor
01/21/10Cancer sensitizer comprising glucosamine, glucosamine derivatives or salts thereof
09/12/13Method and composition for the treatment, prevention, and diagnosis of cancer containing or derived from cancer stem cells

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with National Cancer Center in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for National Cancer Center with additional patents listed. Browse our Agent directory for other possible listings. Page by